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Background: Many patients experience difficulties adhering to medication regimes. For 
people who forget or get confused about medication, there are products to help them 
such as multi-compartment medication devices (MMDs). Some of these, known as 
electronic MMDs (eMMDs),  use audible and/or visual signals to prompt the patient when 
to take  medication, dispense medications, give instructions to the patient, and contact a 
caregiver (mobile internet or text to a carer) as needed.   
Aim: To systematically review the literature on the use of eMMDs, to determine what 
evidence for their effectiveness is available. 
Methods: A comprehensive literature search of 10 databases, plus an internet search 
and hand searching was conducted, using the MeSH terms reminder systems/patient 
compliance/medication adherence. There were no date restrictions. Inclusion criteria 
were patients in any community setting, in any country and with no restrictions of age, 
gender, ethnicity or medical condition, using an eMMD.  Peer-reviewed quantitative or 
qualitative studies of any design were included.    
Results: Of 805 abstracts identified and 99 full text papers retrieved, six met the 
inclusion criteria. Five of the studies reported adherence to medication regimes; one 
reported design factors to improve adherence. Adherence varied by the context of the 
reminders, the target group and usability of the devices. The studies were small scale 
and only one was a well conducted randomised controlled trial.     
Conclusion: Overall methodological quality of the studies was poor. Although positive 
effects on adherence were reported further, rigorously conducted, studies are needed to 
inform the use of eMMDs. 
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15 million UK adults1 are living with chronic disease, 30% of whom have multiple 
morbidity requiring polypharmacy, and many have some level of cognitive impairment.  
This number is estimated to double by 20302. Medication adherence problems are 
common and associated with poor disease control including hospitalisation and death3-8.  
There are also other financial implications; it has been estimated that in the UK the cost 
of medications unused and returned to pharmacists9 is £100 million per annum. 
 
Non-adherence may be unintentional or intentional.  Unintentional non-adherence is 
usually due to practical problems such as poor instructions, poor memory or cognitive 
defects or difficulty in opening packaging.  Intentional non-adherence is largely 
associated with poor motivation and negative beliefs about medication10. While both 
types of non-adherence can result in failure to take any of the medicine, the most 
common form of non-adherence is doses missing because of forgetfulness, changed 
medication schedules or busy lifestyles11.  
 
A review12 of medication adherence identified four general categories to improve 
adherence: patient education; improved dosing schedules; increased access to health 
care; and improved communication between physicians and patients. Strategies to 
improve dosing schedules were described, including the use of pillboxes to organize daily 
doses, simplifying the regimen to daily dosing, and cues to remind patients to take 
medications.  Another review13 which assessed current research on determinants of 
patient adherence found that multifaceted interventions are most likely to improve 
adherence. A recent Cochrane review14 of interventions to improve adherence found that 
while almost all of the effective interventions were complex these did not lead to large 
improvements in adherence and treatment outcomes.  
 
A Kings Fund report on polypharmacy15 noted that adherence problems increase as 
medicine regimens become more complex. It concluded that there is a need to develop 
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systems that optimise medicines use for patients taking multiple medications, to   
maximise benefit, minimise risk and reduce harm and waste. Solutions proposed 
included training programmes, improved electronic decision support for clinicians and/or 
patients, patient-friendly information systems, the use of monitored dose systems and 
clinical audit.  A report on the use of multi-compartment compliance aids16 (MCAs) 
concluded that MCAs may be of value for some patients who have been assessed as 
having practical problems in managing their medicines. The ease of use of MCAs has also 
been investigated17 as problems with accessing medication from its packaging in a MCA 
had been reported by 54% of participants. This suggests that modifications need to be 
made and it may be that electronic storage and dispensing methods with reminder 
systems could be a useful addition if they are found to increase adherence.  
 
There are now electronic Medicine Management Devices (eMMDs) that can prompt the 
patient when to take a medicine using audible and/or visual signals, dispense medicines 
at the appropriate times, give instructions to the patient, and contact a caregiver 
(usually by mobile technology) if medicines are not removed or are not taken at the 
right time.  Reminders and alerts can be set up by health care professionals or carers. 
Such devices are heavily promoted by manufacturers and described in government 
policy documents18.  However, it is not known if these electronic devices provide any 
advantage over regular MMDs in terms of better adherence to a medication plan.   
The aim of this systematic literature review was to determine: if there is evidence that 
the use of eMMDs improves adherence; for which patient groups and for which condition 
types they are most likely to be successful in improving adherence and health outcomes; 
how acceptable are they to users, carers and health care professionals and if there is 
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Studies were included from all community settings and countries and no restrictions 
were made in terms of patients’ age, gender, ethnicity, medical condition or types of 
medication. Peer-reviewed qualitative and quantitative studies of all designs were 
included.   
Studies investigating multi-compartmental devices which met at least one of the 
following criteria were included: 
1. Prompted the patient when to take a medicine using audible and/or visual signals 
and/or dispensed medicines at the appropriate times. 
2. Gave instructions to the patient, and/or contacted a caregiver if medicines were 
not removed or were taken at the wrong time.  
Outcomes 
Outcomes to be collected included adherence measures, clinical outcomes, usability, and 
satisfaction with the intervention.  
 
Search methods for identification of studies 
The MeSH terms for the database search were reminder systems/ patient compliance/ 
medication adherence. See Appendix 1 for detailed search terms. 
 
The databases of the Cochrane Central Register of Controlled Trials (Trials along with 
EED and HTA) and the Database of Abstracts of Reviews of Effects (DARE), MEDLINE, 
EMBASE, CINAHL, EBSCO, PsycINFO, Scopus, ASSIA and Web of Science were searched. 
Current Controlled Trials was searched to identify trials in progress. The Internet was 
searched using the Google academic search engine (http://scholar.google.com) looking 
at the first 300 returns on the relevance ranking, electronic reminder system 
manufacturers contacted, and abstracts from the Pharm-line database checked. Internet 
search terms were based on the MeSH terms for drug administration and drug delivery 
systems and reminder systems along with the specific trade names.  Reference lists of 
papers retrieved in full text for relevant studies were also searched.  Hand searches of 
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journals and meetings abstracts were carried out. There were no language restrictions 
applied in the initial search, however full text versions of papers not published in English 
were excluded as no translation service was available.  There were no date restrictions.   
 
Selection of studies 
The search strategy (see Appendix 1) was implemented by MP on 26 March 2014 and 
references imported to Endnote and duplicates removed.  MP checked all the titles and 
abstracts of potentially relevant studies and these were independently checked by at 
least one other member of the research team. Full text copies of potentially relevant 
studies were obtained and these were assessed by MP and one other member of the 
team for their eligibility for inclusion against the criteria outlined above. Disagreements 
were resolved by discussion. 
   
Data extraction and management 
The following data were extracted by two independent reviewers (MP and one other 
member of the team) from the studies using a customised data extraction form in Excel: 
 Country and setting 
 Study design 
 Participants (sample size, mean age, gender ratio) 
 Medical condition/medication 
 eMMD system 
 Adherence measure  
 Other reported outcomes including clinical outcomes,  acceptability, barriers and 
facilitators to the use of eMMDs,  the experience and usability of the devices   
 Study tools e.g. questionnaire 
 Costings 
 
Quality assessment and reporting biases in included studies 
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Studies were assessed for the risk of potential bias using the Critical Appraisal Skills 
Programme (CASP)19 questions as appropriate to the study design.  For randomised 
controlled trials (RCT) this included allocation procedures, blinding, attrition, power of 
study and whether positive results had been stressed over negative results. For a cohort 
study this included: the population, subjective or objective measures, accuracy of 
outcome measurement to minimise bias, and consideration of confounding factors if they 
were identified.  For a qualitative study this included the rigour of data collection, the 
type of analysis and clarity of the statement of findings. Using the answers to the 
questions as an indication of quality, an overall quality assessment for each study was 
determined.  
 
Summary measures and synthesis of results 
Where available, the difference in mean adherence was reported. Otherwise the studies 
are reported narratively.  
 
RESULTS 
Study selection  
A total of 805 titles/abstracts was identified. After removal of duplicates 749 abstracts 
were screened, of which 650 were excluded as they contained no explicit mention of 
electronic reminders. Full text articles were obtained for the remaining 99.  Three 
articles, identified from citation lists or the grey literature were rejected because they 
had not been peer reviewed.  The PRISMA chart is shown in Figure 1.    
 
Study characteristics 
Six articles met the full inclusion criteria and the main characteristics are summarised in 
Table 1.  The studies were conducted between 2008 and 2013, in countries in North 
America, Europe and Asia.  There was a range of study designs from observational 
studies (3), a controlled longitudinal study (1) and RCTs (2). The studies used eMMDs 
with different levels of sophistication of electronic reminders but all with alarms that 
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were triggered by different contextual factors or with the facility to contact users or 
carers.  Hayakawa et al.20 interviewed 116 patients attending (as outpatients) 
cardiovascular or metabolic disease departments to inform the development of an eMMD, 
followed by a feasibility study in which 10 patients used the device.  Hayes et al.21 used 
adherence to vitamin pills to explore the effectiveness of a complex reminder 
intervention in 10 elderly people where forgetfulness was an issue. Lo et al.22 carried out 
an ethnographic study observing the use of an eMMD followed by a satisfaction survey of 
30 healthy volunteers to explore the desired properties and the barriers to use of such a 
device. Schmidt et al.23 conducted a controlled longitudinal study of 62 patients with 
high blood pressure and congestive heart failure (CHF) taking antihypertensive 
medication to determine if an eMMD could improve adherence.  Simoni et al.24 used an 
eMMD combined with cognitive behavioural therapy (CBT) in a RCT with 40 HIV positive 
patients with depression taking anti-retroviral medication. Stip et al.25 tested an eMMD in 
a RCT of 47 people with schizophrenia taking anti-psychotic medications.   
 
Effects of the intervention on adherence rates 
Hayakawa et al. tested the design and feasibility of a smartphone based reminder 
system which linked wirelessly to a pillbox and included real-time medication monitoring.  
According to the self-reports from 116 interviews 46 (41.1%) patients forgot to take 
their medication, or took their medication more than two hours behind schedule, more 
than once a week. In the feasibility study of the pillbox with 10 patients, delay in taking 
medicine within the scheduled time occurred 47 times out of 127 (37.0%) and in 17 of 
the 47 occasions (36.2%) patients took their medication upon being presented with only 
one reminder.  
 
Hayes et al. compared three types of reminder systems in older patients who lived alone 
and were considered to be poorly adherent.  They reported that adherence rates varied 
with the situation in which prompts were administered. Context-aware prompting which 
only occurred when participants had forgotten to take their pills and were in a situation 
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where they were likely to be able to take their pills, resulted in a mean adherence of 
92.3% (95% CI 84.7-97.0).  Using time based reminders alone adherence was 73.5% 
(95% CI 68.0-78.6), and with no prompting 68.1% (95% CI 57.5-80.5). Adherence was 
tracked by the eMMD.   
 
Schmidt et al. studied adherence when using an eMMD in patients with CHF taking 
antihypertensive medication who had self-reported or physician reported compliance 
problems (n=32). Medication intake data was transferred by the eMMD to an electronic 
health record and was monitored by health care professionals.   Compliance was 
measured by the number of interventions needed to remind patients to take medication 
if they failed to take medication when the alarm went off.  More than 50% of patients 
made only 0-2 mistakes during the 2 month period although this varied greatly with one 
patient needing 19 interventions.   
 
Simoni et al. conducted a RCT to examine the efficacy of a CBT intervention for 
depression used simultaneously with an eMMD (Medsignals®), compared to an identical 
pillbox with the alert system deactivated and with no CBT, in patients with HIV receiving 
antiretroviral therapy who were sub-optimally adherent.  Adherence was monitored by 
self-reports using a visual analogue scale26 and an embedded log in the pillbox that 
recorded compartment openings and uploaded the data to a web based system. They 
reported that greater adherence was recorded by the intervention group using the eMMD 
with an odds ratio of 3.78 (SE=1.31, 95% CI=1.62-7.26, p=0.001).  Similar findings 
were reported for the self-reports (OR=3.34, SE=1.31, 95% CI=1.62-7.26, p=0.001).  
 
Stip et al. conducted a RCT to test if an eMMD (DoPill®) with an alarm and real time 
information improved adherence in schizophrenic patients taking anti-psychotic 
medications compared with a control group using a Medication Events Monitoring System 
(MEMS®) device which only recorded openings. The use of the eMMD showed a mean 
antipsychotic adherence rate (AAR) (number of pills taken / number of pills prescribed X 
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100) of 67% which was comparable for both devices.  The raw results indicated that 
more adherent patients at baseline evidenced greater improvement in adherence relative 
to more non-adherent patients, with ARRs of 98-100% when using the eMMD.  This 
suggests there may be a limit to the benefit that electronic aids can have for increasing 
adherence in those who are not simply forgetful.  Adherence was also measured by the 
Brief Adherence Rating Scale (BARS) ratio, a self-report and clinician assessment of 
adherence which is used to assess medication adherence in schizophrenia and was 
reported in the literature27 to show an AAR of about 49.5% in the general schizophrenic 
population.   The AAR measured by BARS in this study was found to be 86-99% 
suggesting that BARS was not an accurate indicator of adherence in this group of 
participants.   
 
Effects of the intervention on health outcomes  
Simoni et al. reported improved biological markers of cell counts for HIV viral load for 
patients taking antiretroviral drugs and psychological indicators of depressive symptoms 
using the Beck Depressive Inventory-1A (BDI-IA) and the Montgomery-Åsberg 
Depression Rating Scale (MADRS). The primary depressive symptoms outcomes were 
assessed with a self-report on the BDI-IA and a semi-structured interview by an 
independent rater blind to treatment condition using the MADRS.  Intervention 
participants demonstrated a greater drop in depressive scores in BDI-IA scores (OR = -
3.64, SE=1.78, 95% CI=-7.26 to 0.01, p = 0.05) and to a lesser extent MADRS scores 
(OR=-5.14, p=0.14).  Biological markers indicated some relative improvement for CD4 
cell count (OR = 69.45, SE = 38.57, 95 % CI = -6.16 to 145.05, p = 0.07), but not for 
viral load (OR=0.14, 95%CI=-0.75-1.03, p=0.75).  
 
Schmidt et al. compared the intervention group with a control group of CHF patients 
(n=30) who did not have adherence problems, did not use the eMMD and had better 
mental and physical health at baseline.  They found a significant improvement in mental 
health in the intervention group based on self-reported health status in the 12-Item 
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Short Form Health Survey27 (T= -3.09, p≤0.01) from baseline to the 2 month 
assessment.  The mental health of the control group did not change significantly 
(T=1.81, p=0.05) in this time. 
 
Usability issues 
Lo et al. found an eMMD could enhance adherence if it could be used flexibly in different 
contexts, was not too large, the alarm was not so intrusive that it overcame privacy if 
used outside the home and interface complexity was reduced to simplify the operating 
system. Older adults in the feasibility study of 30 patients (15 > 65 years, 15 < 65 
years) preferred a pillbox that integrated both pillbox and reminder functions rather than 
using a separate mobile phone as the reminder.  Hayakawa et al. found 51 out of 112 
(45.5%) took their medications outside the home more than once a week, suggesting 
that portable pillboxes may support medication self-management.  Schmidt et al. found 
the features with the most potential for improvement were more flexible programme 
timing and mobile solutions for the pillbox. Hayes et al. identified benefits for the elderly 
in not being required to carry medication dispensers but rather having a system that 
monitors their movements to determine when medication prompting should be carried 
out.  
 
Limitations of the studies 
All the studies included in the review had methodological problems.  They were limited 
by small numbers, inadequate control groups and often included complex interventions 
of which adherence technology was only a part.  The limitations are summarised in Table 
2.  The CASP quality assessment tools were used to determine the quality but due to the 
mixed methods used by the studies a full comparison was not meaningful. A cost 
analysis was not reported in any of the included studies. 
 
DISCUSSION  
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This review suggests eMMDs may improve adherence.  However all the studies had 
methodological limitations, and larger, well conducted controlled trials, with longer term 
outcomes are required to confirm this.  Studies of eMMDs use the technology as both the 
intervention and the tool to measure adherence, which may introduce bias.  Furthermore 
most of the studies in this review were at the feasibility stage and did not report in detail 
on clinical outcomes.  The elderly with cognitive problems and patients with conditions 
where timing and adherence to medication regimes are critical were the groups most 
likely to benefit from these more sophisticated reminder devices. The usability, mobility 
of the device and the flexibility of timing of reminders were identified as issues that still 
need to be addressed.  
 
The review process also had several limitations.  As with all literature searches not all 
eligible papers may have been identified, although the search was comprehensive and 
was checked by experts in information science.  Secondly, the quality of the studies was 
poor, and heterogeneity across the studies meant it was not possible to fully combine 
the results.  Although other papers were identified outside the database search the lack 
of peer review meant they could not be included.  Non-English publications were also 
excluded but they were few in number. 
 
Previous reviews in this area have focused on electronic reminders but not particularly 
on eMMDs. A review by Fenerty 29 found no significant difference in adherence rate for 
patient reported results compared to electronic monitoring systems. It was unclear 
whether one type of reminder system had a significant impact on adherence.  The review 
concluded that the type of medication could influence the adherence rate and that 
chronic and asymptomatic illnesses may be most resistant to adherence-enhancing 
strategies. Similarly Vervolet 30 reviewed studies using electronic reminders but only one 
of the papers in this review concerned an eMMD and this was included in our review. The 
review provided evidence for the short term effectiveness of electronic reminders but the 
effects in the long term were unclear. 
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CONCLUSION  
This review showed that electronic reminders combined with MMDs may have the 
potential to lead to improvements in patients’ adherence to medication but the context, 
usability and medical condition influence their usefulness. Further high quality studies in 
a range of contexts are required to establish if the use of eMMDs as a long term aid or 
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Type of MMD Type of electronic reminder/ 
telehealth system 







aged 67.8 ± 
12.1),  







Wireless 7 day 
pillbox for use 




Smartphone with medication history and 
recording of medicine taking and with 
reminder provided as a message from 
wireless electronic pillbox to smartphone 
via Bluetooth only when patient forgets to 
take medication. If medication taken but 
not on time, manually entered into 
smartphone. If box opened more than 
once within defined timeframe, patient 
alerted to prevent double dose. 
Effectiveness of reminder: 
Not taking medicine within the 
time scheduled occurred 47 times 
out of 127 times (37%).  In 17 
times of the 47 occasions 
(36.2%) patients took their 
medication upon being presented 
with a single reminder.  
In the feasibility study 8 out of 10 
reported they thought reminders 
were effective. 8/10 were 
satisfied with system, 7 wanted 
to continue use it. 
Hayes 2009 
 






10 elderly (over 




than 20% of 
prescribed doses)  
 
Vitamin C 
7 day pillbox Auditory beep and visual alarm on 
MedTracker device 
 
Prompting: no prompting, time-based 
prompting and context aware prompting 
(in which participants were only prompted 
if they forgot to take their pills and were 
likely to be able to take their pills which 
included using telecare devices such as 
motion, bed and phone sensors). 
Adherence: Context based 
prompting the mean adherence 
was 92.3% (95% CI 84.7-97.0), 
in time-based prompting 73.5% 
(95% CI 68.0-78.6), and with no 
















problems and had 
taken medicines 






7 day pillbox 2 systems: Pillbox software on iphone 
which shows visual picture of medicines 
which should be taken. Medication time 
could be set and an alarm sounds. After 
taking the medicine from the non-
electronic pillbox, the user needs to tap 
the picture of the pills on the screen.  A 
record of the medicines taken/missed is 
available. Also tested was an electronic 
pillbox which stores medicines and had 
reminder alarm. 
Qualitative outcomes:  
The older aged group preferred 
an integrated pillbox. 
The participants could hear the 
reminder on the phone but forgot 
to take the non-electronic pillbox 
with them. 
 








compliance.   
 
 
62, Study 32, 
Control 30. 




no need for 
medication 
compliance. 










box with 28 
containers 
for pills or 
capsules 
An alarm sounded at the programmed 
time of intake, and it stopped only when 
medication was taken out and the box 
turned around so that a mechanical sensor 
registered intake. Medication intake data 
was transferred by the eMMD to an 
electronic health record and was 
monitored by health care professionals 
Adherence: Measured by number 
of interventions needed after 
reminder. More than 50% of 
patients made 0–2 mistakes 
during the 6-month study period,. 




reported compliance and the 
electronic measure was high with 
patients in the study group who 
reported as non-compliant 
showing significantly lower 
compliance scores (T=9.71, 
p<0.001). 
The medication box was well 
accepted by the patients in the 
study; 83% regarded the tool as 
very good or good. Acceptance 
was not associated with age (r = 
0.12, p > 0.05), but with gender 
- male. 51% of the patients felt 
that they would like constant 
monitoring in the future, while 
49% of patients preferred it only 
for interim use.  Mental health 
improved in both groups based 
on SF-12, significantly in the 
study group (T= -3.09, p≤0.01), 
control (T=1.81, p=0.05).There 
were already significant 
differences between control and 




RCT to test 
adherence 





ranging in age 
from 24 to 63 
years; 73 % were 
male. 
 







up to 4 meds  
The pillbox was portable, provided storage 
for up to four medications, prompted 
correct dosing times and warnings, and 
recorded data on bin openings that could 
be uploaded through a telephone line or 
directly to a computer during a clinic visit. 
 
Greater adherence with the 
electronic pillbox (OR = 3.78, 
SE=2.26, 95%CI=1.17-12.18, p 
= 0.03). 
Also greater adherence when 
measured with visual analogue 
scale self-report percentage 
adherence outcome (OR=3.34, 




demonstrated a greater drop in 
depressive scores in the Beck 
depression inventory (BDI) scores 
(OR = -3.64, SE=1.78, 95% CI=-
7.26to0.01, p = 0.05) and to a 
lesser extent Montgomery–Åsberg 
Depression Rating (MADRS) 
(OR=-5.14, p=0.14)  
Biological markers for CD4 cell 
count showed relative 
improvement (OR = 69.45, SE = 
38.57, 95 % CI = -6.16 to 
145.05, p = 0.07), but this was 
not maintained at 9 month follow 
up (OR=25.71, SE=43.17, 
95%CI=-58.91 to 110.32, 
p=0.55) and not Viral Load 
(OR=0.14, 95 p=0.75). 
















47 (26 eMMD /21 
control) 












buzzer  plus 
pharmacist 
informed 
Visual and sound alarms, sensors to 
record opening and upload data. 
Adherence: rate recorded by 
DoPill® over the 6 weeks of use 
was 66.6% [secure digital (SD) 
35.1]. Comparable rate for 
controls with MEMS®   
BARS scores were 86–99% for 
adherent and non-adherent 
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Table 2   Quality and limitations of included studies 
Study Limitations Quality comments Quality score 
Hayakawa et al Small uncontrolled usability study to 
inform development of pillboxes. 10 
participants tested preferred system.   
 







Hayes et al Small uncontrolled study.  10 
participants in complex system using 10 
homes that were wired up to use several 
telecare devices. Fairly complex - may be 
of limited generalizability. 
 





Lo et al Usability study with 30 participants to 
inform development of pillboxes.  




Schmidt Inadequate control group which 
consisted of patients not considered to 
need compliance aids and with different 
physical and mental health. 
 
 Low 
Simoni et al The outcome was related to two 
interventions (CBT and the eMMD) used 
simultaneously - difficult to be sure to 
what extent the eMMD contributed to 
the overall improvement in outcome. 
 
Study was a well-
constructed RCT of 40 
participants, adequately 




Stip et al The method for the RCT was not well 
described. There was no mention of how 
randomisation occurred or allocation 
concealment, no power calculation and 
no analysis of drop outs.  The results 
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